Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|S1|47-51

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.S1, 2018-02, pp. : 47-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnosis of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: Non‐invasive tests are enough

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 67-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnosis of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: Why liver biopsy is essential

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 64-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

Future therapy for non‐alcoholic fatty liver disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 56-63

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease

By Smith Briohny W.   Adams Leon A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Iss. 3, 2011-06 ,pp. : 97-113

Informa Healthcare

Access to resources Recommend Favorite

Failure of islet β‐cell compensation for insulin resistance causes type 2 diabetes: What causes non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis?

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 10, 2010-10 ,pp. : 1594-1597

John Wiley & Sons Inc

Access to resources Recommend Favorite